Ampio Pharm (AMPE) Financials

$0.18

$-0.44 (-70.47%)

As on 05-Jun-2026 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.25	2.08	1.09	1.18	1.27	0.52
Gross Profit	-0.25	-2.08	-1.09	-1.18	-1.27	-0.52
Operating Expenses	9.27	18.30	19.48	15.83	17.30	9.90
Operating Profit (EBIT)	-9.52	-20.38	-20.57	-15.83	-18.58	-11.18
Other Income	--	--	3.49	-0.07	4.87	--
Profit before Tax	-8.63	-16.34	-17.08	-15.89	-13.63	33.99
Provision for Tax	--	-7.87	-4.59	0.60	-4.95	45.17
Profit after Tax (Net Income)	-8.63	-16.34	-17.08	-15.89	-13.63	33.99
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	-16.34	-17.08	-15.89	-13.63	33.99

Liabilities ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	3.36	11.79	27.28	17.51	6.44	5.24
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	0.61	6.42	3.53	3.27	7.41
Current Liabilities	2.38	1.19	5.12	1.83	4.28	1.38
Total Liabilities	5.74	13.59	38.83	22.88	14.00	14.03

Assets ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	0.14	0.26	3.19	4.39	5.75	6.03
Current Assets	5.74	13.33	35.63	18.49	8.25	8.00
Total Assets	5.74	13.59	38.83	22.88	14.00	14.03
Total Debt*	0.27	0.80	1.19	1.21	1.47	--
Net Current Assets	3.36	12.14	30.51	16.66	3.97	6.61

Cashflow ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	-8.56	-21.13	-14.09	-14.73	-15.38	-12.14
Cash Flow from Investing Activities	--	--	-0.10	-0.06	-0.02	-0.56
Cash from Financing Activities	0.10	-0.11	30.73	25.61	0.01	0.01
Net Cash Inflow / Outflow	--	--	16.55	10.81	-1.05	-0.62

Financials Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-10.40	-21.68	-24.01	-25.47	-26.60	88.39
Cash EPS ($)	-10.03	-20.29	-22.47	-23.58	-24.12	91.72
Adjusted Book Value ($)	4.05	15.64	38.36	28.06	12.57	13.62
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-10.32	-28.04	-19.81	-23.60	-30.02	-31.57
Free Cash Flow per Share ($)	-10.32	-28.04	-19.94	-23.71	-30.06	-33.04

Profitability Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	-106.40	-79.56	-72.35	-119.36	-207.33	-234.87
ROE (%)	-113.96	-83.62	-76.23	-132.70	-233.41	-234.87
ROA (%)	-89.34	-62.34	-55.35	-86.20	-97.25	231.63
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	-488.97	22,075.00	-279.93	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	64.34	-41.77	-8.32	-16.31	-139.88	316.77
Net Profit Growth (%)	47.16	4.32	-7.43	-16.61	-140.10	165.49
EPS Growth (%)	0.52	0.10	0.06	0.04	-1.30	1.43
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	-0.20	-0.01	-0.02	-0.06	-0.02	0.00
Price / Book Value	0.51	0.01	0.01	0.06	0.05	0.03
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.26	0.50	2.02	1.04	0.39	-0.21
Close Price ($)	2.05	4.50	171.00	477.00	174.90	118.44
High Price ($)	8.30	194.10	777.00	894.00	393.00	1,227.00
Low Price ($)	1.73	3.98	158.70	93.00	78.00	105.33
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	0.08	0.07	0.04	0.07	0.23	--
Short term debt to equity ratio	0.08	0.04	0.02	0.02	0.08	0.01
Current Ratio	2.41	11.18	6.96	10.08	1.93	5.78
Quick Ratio	2.41	11.18	6.94	9.94	--	--
Interest Coverage	--	-3.08	-2.11	--	-176.01	6,779.93

Operating Efficiency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	0.00	6.32	56.42	82.48	--	--
Payable days	618.73	46.03	102.33	52.25	123.04	1,219.20
Cash Conversion Cycle	--	--	--	--	--	--